NIFTY23,406▼0.33%

SENSEX74,346▼0.41%

BANKNIFTY54,186▲0.88%

NIFTY IT29,384▼5.57%

PHARMA24,087▲0.33%

AUTO26,093▲0.05%

FMCG48,124▼1.01%

METAL13,535▼0.17%

REALTY762.60▼1.39%

ENERGY40,197▲0.02%

NIFTY23,406▼0.33%

SENSEX74,346▼0.41%

BANKNIFTY54,186▲0.88%

NIFTY IT29,384▼5.57%

PHARMA24,087▲0.33%

AUTO26,093▲0.05%

FMCG48,124▼1.01%

METAL13,535▼0.17%

REALTY762.60▼1.39%

ENERGY40,197▲0.02%

IPOMar 2, 2026

Dorf Ketal Seen Delaying IPO Amid Italmatch Acquisition Talks

Dorf Ketal Chemicals India Ltd. IPO Deferred

Dorf Ketal Chemicals India Ltd., a Gujarat-based chemicals manufacturer, has reportedly put its initial public offering (IPO) on hold. The company is instead seeking to raise up to ₹2,000 crore in a pre-IPO funding round.

The decision to defer the IPO is part of Dorf Ketal Chemicals India Ltd.'s strategy to secure additional capital before proceeding with a public listing. The company aims to leverage the pre-IPO funding to support its growth initiatives and strengthen its financial position.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Investor Takeaway

Investors should be cautious about Dorf Ketal's IPO plans due to potential delays.

More in IPO

IPO·8h ago

SMR Jewels IPO Successfully Lists with Institutional Support

IPO·9h ago

Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

IPO·9h ago

Merritronix IPO Sees Robust Subscription, Oversubscribed by 293 Times on Final Day

IPO·9h ago

CMR Green Technologies IPO Sees Strong Demand on Listing Day, Subscribed 2.45 Times

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

News eBooks

Company

Home Privacy Policy Terms of Service

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.